MedPath

The Japan Hypertension Evaluation with Angiotensin 2 Antagonist Losartan Therapy

Not Applicable
Conditions
Hypertension
Registration Number
JPRN-UMIN000006149
Lead Sponsor
MSD KK
Brief Summary

Blood pressure was well controlled during the study period by losartan alone or losartan-based combination therapy.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30000
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with a history of losartan treatment at any period were excluded from the study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Stroke, MI
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath